SCHEMBL15948966

SCHEMBL15948966

Cc1cc(=O)c(OCc2ccccc2)cn1CC(F)F

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 5/20 0.43
PTGER1 P34995 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
P2RX7 Q99572 3/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
PKM P14618 1/20 0.40
MAOB P27338 1/20 0.40
BRD4 O60885 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17128903 0.83 MAPK14 (0.44) MAPK14PTGER1SMN1; SMN2MAPTMAPK1
SCHEMBL12949558 0.82 MRGPRX4 (0.41) PTGER1MEN1KMT2ABRD4MRGPRX4
SCHEMBL12949645 0.82 MAPK14 (0.43) MAPK14PTGER1SMN1; SMN2MAPTMAPK1
SCHEMBL28377949 0.81 MAPK14 (0.44) MAPK14PTGER1SMN1; SMN2MAPTMAPK1
SCHEMBL16744408 0.78 MAPT (0.47) MAPK14SMN1; SMN2MAPTMAPK1TDP1
SCHEMBL2118755 0.78 MAPK14 (0.42) MAPK14SMN1; SMN2MAPTMAPK1TDP1
SCHEMBL12949559 0.75 MAPK14 (0.41) MAPK14SMN1; SMN2MAPTMAPK1TDP1
SCHEMBL2118516 0.75 MAPT (0.41) MAPK14MAPTMAPK1TDP1L3MBTL1
SCHEMBL12949756 0.73 SMN1; SMN2 (0.71) MAPK14SMN1; SMN2MAPTMEN1ALDH1A1
SCHEMBL27937435 0.73 COMT (0.44) MAPTMAPK1TDP1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9938240-B2 Fluorinated derivatives of 3-hydroxypyridin-4-ones APOTEX INC. (CA) 2018-04-10 US disclosed
US-9938240-B2 Fluorinated derivatives of 3-hydroxypyridin-4-ones APOTEX INC. (CA) 2018-04-10 US disclosed
US-9938240-B2 Fluorinated derivatives of 3-hydroxypyridin-4-ones APOTEX INC. (CA) 2018-04-10 US disclosed
US-20170247329-A1 \"Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones\ APOTEX TECHNOLOGIES INC. (CA) 2017-08-31 US disclosed
US-20170247329-A1 \"Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones\ APOTEX TECHNOLOGIES INC. (CA) 2017-08-31 US disclosed
US-20170247329-A1 \"Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones\ APOTEX TECHNOLOGIES INC. (CA) 2017-08-31 US disclosed
US-20170088518-A1 Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones THE BANK OF NOVA SCOTIA (CA) 2017-03-30 US disclosed
US-20170088518-A1 Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones THE BANK OF NOVA SCOTIA (CA) 2017-03-30 US disclosed
US-20170088518-A1 Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones THE BANK OF NOVA SCOTIA (CA) 2017-03-30 US disclosed
US-9550733-B2 Fluorinated derivatives of 3-hydroxypyridin-4-ones APOTEX TECHNOLOGIES INC. (CA) 2017-01-24 US disclosed
US-20150335626-A1 FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES APOTEX INC. (CA) 2015-11-26 US disclosed
US-20150274665-A1 FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES FLORIDA TURBINE TECHNOLOGIES, INC. 2015-10-01 US disclosed
US-20150274665-A1 FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES FLORIDA TURBINE TECHNOLOGIES, INC. 2015-10-01 US disclosed
US-20150274665-A1 FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES FLORIDA TURBINE TECHNOLOGIES, INC. 2015-10-01 US disclosed
US-9073865-B2 Fluorinated derivates of 3-hydroxypyridin-4-ones APOTEX TECHNOLOGIES INC. (CA) 2015-07-07 US disclosed
US-9073865-B2 Fluorinated derivates of 3-hydroxypyridin-4-ones APOTEX TECHNOLOGIES INC. (CA) 2015-07-07 US disclosed
US-9073865-B2 Fluorinated derivates of 3-hydroxypyridin-4-ones APOTEX TECHNOLOGIES INC. (CA) 2015-07-07 US disclosed
EP-2448922-B1 FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES APOTEX TECHNOLOGIES INC (CA) 2014-08-20 EP disclosed
EP-2448922-B1 FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES APOTEX TECHNOLOGIES INC (CA) 2014-08-20 EP disclosed
CN-102712591-B Fluorinated derivatives of 3-hydroxypyridin-4-ones APOTEX TECHNOLOGIES INC 2014-06-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150335626-A1 FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES FH, FECH, TFRC MAPK14 1371/4885PTGER1 1078/4885SMN1; SMN2 627/4885
US-20170088518-A1 Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones FH, FECH, FPGS MAPK14 1757/4885PTGER1 1173/4885SMN1; SMN2 397/4885
US-20170247329-A1 \"Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones\ FH, FECH, FPGS MAPK14 2203/4885PTGER1 790/4885SMN1; SMN2 363/4885
US-20150274665-A1 FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES FH, FECH, TFRC MAPK14 1371/4885PTGER1 1078/4885SMN1; SMN2 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.